GitLab
Preço: 27.79Empresa e modelo de negócios
GitLab is a technology company that provides a DevOps platform for software development, enabling teams to collaborate on code, manage projects, and automate workflows. Its core products include source code management, continuous integration and delivery, and security features. Major business segments encompass enterprise solutions and cloud services, with primary revenue sources derived from subscriptions and professional services.
Perfil de investimento
The investment profile of GitLab is more aligned with growth investors, given its focus on expanding its market presence and enhancing product offerings. The company shows potential for revenue growth, although it carries a higher risk profile. Investors seeking a balanced approach may find it suitable, but the absence of dividends limits its appeal for income-focused strategies.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- -0.15 Risco
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 1.4% ≈
- Surpresa de EPS
- 15.0% melhor que o esperado
- Volatilidade 20d
- 4.6% estável
Impacto da previsão
positivoAcompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-05-08 15:08 | — | Manter | Recent gains offset by high volatility and negative momentum. |
| 2026-05-04 02:40 | Vender | Manter | Компания показывает положительную динамику в краткосрочной перспективе, однако долгосрочные показатели остаются негативными, что указывает на высокие риски. |
| 2026-04-09 03:07 | Manter | Vender | Компания демонстрирует значительное снижение цены акций за последние месяцы, а отрицательный EPS указывает на финансовые проблемы. Растущий риск и низкий потенциал роста делают акцию менее привлекательной для инвестирова |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-06-03 13:18 | D.A. Davidson | Preço-alvo elevado | 24 → 35 | 30.38 |
| 2026-06-03 12:07 | UBS | Preço-alvo elevado | 24 → 32 | 30.15 |
| 2026-06-03 11:51 | Wolfe Research | Preço-alvo elevado | 32 → 36 | 31.82 |